Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
Although gefitinib has been combined successfully with various chemotherapeutic regimens with
minimal increase in overall toxicity, experience with concurrent radiation therapy is
limited. In this trial, we will evaluate the feasibility, toxicity, and effectiveness a novel
combination of chemotherapy, radiation therapy, and gefitinib.